Company
Rivas Medical Weight Loss
Rivas Medical Weight Loss publishes compounded semaglutide and compounded tirzepatide, from $460 to $660 a month.
- 2 programs
- 2 molecules
- 2 readings
Read from rivasweightloss.com on September 2, 2026. This page records what the company publishes. It is not a review and takes no position on the company.
Go to Rivas Medical Weight Loss
We earn nothing from this link. Rivas Medical Weight Loss has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.
What it costs
first month, including the required fees on record · ◯ $460 advertised · Weekly pay-as-you-go
first month, including the required fees on record · ◯ $660 advertised · Weekly pay-as-you-go
Terms
| Membership | Required, $195 per month. Wegovy and Zepbound visit fees do not include medication; medication pricing is subject to change and determined at the pharmacy. |
|---|
Not yet checked: pharmacy, consultation fee and states.
Terms can differ between this company’s programs; each entry carries its own.
Programs
Notes
Recorded against this company rather than one program.
September 2, 2026
- 1. Compounded semaglutide/tirzepatide prices are all-inclusive (medication + weekly in-office visit); form confirmed as vial ('Administered from a vial in-office'). By contrast, the Wegovy/Zepbound (brand) telehealth track charges only a visit fee ($195 initial video visit) and explicitly excludes medication cost — a textbook fee-excludes-medication case, recorded as membership with prices left empty for the brand entries. Separately, a one-time $195 initial-visit fee applies to new compounded-tirzepatide patients on top of the weekly rate (not modeled as a price entry). Site clinics are physically in Maryland/Virginia (plus a Fairfax, VA location); footer links a 'Florida Telehealth' page that CONTRADICTS the FAQ's explicit MD/VA-only telehealth statement.
Before you act
Cite this
Treatment Registry. (2026). Rivas Medical Weight Loss: recorded programs and prices. Last verified September 2, 2026. Retrieved [your access date], from https://treatmentregistry.com/providers/rivas-medical